MUC4 and acute myeloid leukemia: Moreover, a reduced overall survival was observed in liver cancer (p = 0.04789) and acute myeloid leukemia (AML) (p = 0.02577) (Additional file 8: Figure S5B) in which we did not show any statistical difference when sorting the patients for MUC4 alone.